This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. It is particularly valuable in the development of drugs targeting the central nervous system, where its structural features contribute to binding affinity and selectivity for specific receptors. The trifluoromethyl group enhances metabolic stability and bioavailability, making it a crucial component in the design of compounds with improved pharmacokinetic properties. Additionally, it is employed in research focused on creating novel therapeutics for conditions such as neurological disorders, depression, and anxiety. Its role in chiral synthesis also supports the production of enantiomerically pure compounds, which are essential for optimizing drug efficacy and reducing side effects.